With an increase in its variety of inpatient and outpatient footfall, greater affected person yield, and the continued ramp-up of newly launched amenities throughout the community, Burjeel Holdings announced a powerful 128.9 per cent soar in internet revenue to AED 148 million (US$40.3 million) within the second quarter of 2025. Internet revenue for the primary six months rose 10.6 per cent to AED 187 million (US$50.9 million).
The rise in internet revenue for Q2 was additionally due to a decline in footfall for the month of March, which was attributed by the corporate to the Holy Month of Ramadan.
These numbers had been overwhelmingly reversed within the second quarter of the 12 months, as inpatient footfall rose 17.7 per cent, and outpatient footfall grew 12 per cent.
Income grew 18.7 per cent to AED 1,403 million (US$382 million) in Q2’25, whereas income for the primary six months rose 12.2 per cent to AED 2,677 million (US$728.9 million). Complete affected person visits reached 3.4 million.
The Group carried out 22,930 surgical procedures, up 18.7 per cent. Mattress occupancy improved to 69 per cent, up from 65 per cent a 12 months in the past. Inpatient volumes rose 14.6 per cent over the primary half.
The outpatient footfall was pushed by major care and physiotherapy facilities, together with sturdy demand in oncology, pediatrics, ophthalmology, and household drugs. Utilisation improved to 68 per cent, up from 65 per cent in Q1’25.
Oncology remained a core progress driver, with income rising 36.7 per cent in Q2’25 and 38.1 per cent in H1’25. This was made doable by oncology community growth and improved conversion in surgical and superior therapies. Different specialties additionally recorded good good points in H1’25, together with urology (+18 per cent), emergency drugs (+17 per cent) and cardiology (+16 per cent).
John Sunil, Chief Govt Officer of Burjeel Holdings, commented: “The second quarter delivered exceptionally sturdy outcomes, with 19 per cent income progress pushed by a 12 per cent enhance in affected person footfall and improved yield. EBITDA rose by 59 per cent, accompanied by a margin uplift to 22 per cent. This strong efficiency considerably strengthened the first-half end result, underscoring Burjeel Holdings’ resilience and long-term sustainable progress.
“These outcomes mirror tangible progress in key operational areas comparable to doctor manpower optimisation, formulary administration, and value management, whereas our strategic give attention to super-specialty care is starting to yield measurable advantages, enhancing each income and profitability. We proceed to put money into high-value companies and next-generation care amenities to assist long-term momentum.
“We additionally superior key strategic priorities, reinforcing management in advanced care throughout oncology, transplants, fertility, psychological well being, and diagnostics. Our oncology platform is now the UAE’s largest non-public community, that includes new most cancers clinics and cell and gene remedy capabilities.”
EBITDA rose 59.4 per cent to AED 306 million (US$83.3 million) in Q2’25, fueled by sturdy income progress, enhanced doctor productiveness, and higher efficiency throughout just lately ramped-up belongings. This contains AED 72 million (US$19.6 million) in good points from lease legal responsibility derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 factors to 21.8 per cent.
In H1’25, EBITDA elevated 14.2 per cent to AED 487 million (US$132.6 million).
“Burjeel Holdings is uniquely positioned to seize vital alternatives throughout the area, supported by rising demand for advanced care and a rising inhabitants. Our focus stays on changing current investments into sustained growth and margin enchancment, whereas sustaining disciplined monetary administration to assist long-term shareholder worth,” Sunil added.
“Internet revenue progress of 129 per cent within the reporting quarter reinforces this trajectory and strengthens the inspiration for constant shareholder returns.”